NFKB1 and rheumatoid arthritis: In accordance with the inhibition of the secretion of cytokines TNF-α, IL-1, and IL-6, astilbin negatively regulates MyD88, p65, and IKKβ protein expression, subsequently leading to the inhibition of the NF-κB pathway for the treatment of chronic inflammation associated with RA.